Oslo Cancer Cluster and NCE Smart Energy Markets together with four European clusters in medicine and IT managed to land a prestigious Horizon 2020 EU project.
The EU project will use innovative IT solutions to develop personalized cancer treatment. Allocated funds is 45 million, of which 34 million is earmarked for small and medium enterprises in the clusters.
The EU project has the name “Personalised Medicine Innovation trough Digital Enterprise Solutions: PERMIDES”, and will utilize the digital revolution to develop new systems for cancer treatment. This will be achieved by matching the small and medium enterprises within IT with cancer biotechs in the six clusters. This matching shall take place both virtually and physically. Utilization of accumulated expertise in Big Data Analytics from other industries, such as energy industry, will enable the development of digital systems and solutions.
“More and more people are diagnosed with cancer, both because the population is steadily increasing, but also because people get older. There is a crying need for innovative cancer treatment. Health care institutions as well as many biotech companies are lagging behind in adopting the latest digital solutions. For Norway in a time of souring oil prizes and in need of new industries, PERMIDES is an important project that will develop solutions for tomorrow’s business community,” says Ketil Widerberg, CEO of Oslo Cancer Cluster.
“The world has just begun to discover the enormous potential Big Data Analytics will represent for society and business. PERMIDES will contribute to research that may save the lives of many people in the coming years. It is the unique competence across clusters that is the core of this project: The transfer of unique Big Data Analytics expertise from smart energy to personalized medicine,” says Dieter Hirdes, F & I Coordinator Smart Innovation Østfold company as a leader NCE Smart cluster .
Source: Oslo Cancer Cluster